Literature DB >> 1428577

Promotion of glaucoma filter bleb with tissue plasminogen activator after sclerectomy under a clot.

A Szymanski1.   

Abstract

Since 1987 we have performed, with good results, glaucoma filtering surgery in which the limbo-scleral fistula was closed by an autogenic full blood clot (sclerectomy under a clot). In 8 patients with advanced stages of glaucoma simplex, 1-3 days after sclerectomy under a clot with rise IOP, 25 micrograms of tissue plasminogen activator (tPA) was injected subconjunctivally. Two weeks after surgery normalization of IOP below 15 mmHg and normal outflow facility in all tPA treated eyes were obtained. No increase in early post-operative complications, such as hemorrhage or corneal haze, was attributable to tPA use. In early period after sclerectomy under a clot, when blockage of outflow appears, the use of tPA can cause the re-creation of filtering tract.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1428577     DOI: 10.1007/bf00917997

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  6 in total

1.  Effects of tissue plasminogen activator on glaucoma filter blebs in rabbits.

Authors:  S Fourman; K Vaid
Journal:  Ophthalmic Surg       Date:  1989-09

2.  Identification of fibrin/fibrinogen in glaucoma filtration surgery wounds.

Authors:  H D Jampel; J Morrison; M Vocci; H Quigley
Journal:  Ophthalmic Surg       Date:  1988-08

3.  Sclerectomy under a clot in surgical treatment of glaucoma.

Authors:  A Szymański
Journal:  Mater Med Pol       Date:  1987 Oct-Dec

4.  Filtering bleb thrombolysis with tissue plasminogen activator.

Authors:  J R Ortiz; S D Walker; P E McManus; L A Martinez; R H Brown; G J Jaffe
Journal:  Am J Ophthalmol       Date:  1988-11-15       Impact factor: 5.258

Review 5.  Wound healing in glaucoma filtering surgery.

Authors:  G L Skuta; R K Parrish
Journal:  Surv Ophthalmol       Date:  1987 Nov-Dec       Impact factor: 6.048

6.  Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator.

Authors:  G J Jaffe; H Lewis; D P Han; G A Williams; G W Abrams
Journal:  Am J Ophthalmol       Date:  1989-08-15       Impact factor: 5.258

  6 in total
  2 in total

1.  Intravitreal injection of tissue plasminogen activator as treatment for an occluded pars plana glaucoma tube.

Authors:  Irena Tsui; Suzanna Airiani; Angie Wen; Tarek El-Sawy; Howard F Fine; Peter J G Maris
Journal:  Clin Ophthalmol       Date:  2009-06-02

2.  Subconjunctival hemorrhage: risk factors and potential indicators.

Authors:  Bercin Tarlan; Hayyam Kiratli
Journal:  Clin Ophthalmol       Date:  2013-06-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.